Warfarin injection Clinical Trials

• Daily Vitamin K in Patients on Warfarin With Unstable INRs
  ClinicalTrials.gov Identifier: NCT00287313 - Recruiting
  Anticoagulants; Warfarin
  
• Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
  ClinicalTrials.gov Identifier: NCT00024297 - Active, not recruiting
  Thromboembolism
  
• Oral Vitamin K for Warfarin Associated Coagulopathy
  ClinicalTrials.gov Identifier: NCT00143715 - Active, not recruiting
  ...
  
• PERIOP 2 - A Safety and Effectiveness Study of LMWH Bridging Therapy Versus Placebo Bridging Therapy for Patients on Long Term Warfarin and Require Temporary Interruption of Their Warfarin.
  ClinicalTrials.gov Identifier: NCT00432796 - Recruiting
  Stroke
  
• Evaluating the use of SR34006 Compared to Warfarin or Acenocoumarol in Patients with Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00070655 - Completed
  Atrial Fibrillation
  
• Warfarin Metabolism and CYP2C9
  ClinicalTrials.gov Identifier: NCT00162474 - Recruiting
  Healthy Voluteers
  
• Warfarin and Antiplatelet Vascular Evaluation
  ClinicalTrials.gov Identifier: NCT00125671 - Active, not recruiting
  Peripheral Vascular Diseases; Cardiovascular Diseases
  
• Access II - Trial of Low-Intensity Adjusted-Dose Warfarin for the Prevention of Mechanical Malfunction of Double-Lumen Haemodialysis Catheters
  ClinicalTrials.gov Identifier: NCT00157651 - Recruiting
  End Stage Renal Disease; Thrombosis; Bleeding
  
• Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00057720 - Active, not recruiting
  Ovarian Neoplasms
  
• Genetic Determinants of Warfarin Anticoagulation Effect
  ClinicalTrials.gov Identifier: NCT00162435 - Recruiting
  Venous Thrombosis; Pulmonary Embolism; Atrial Fibrillation
  
• Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00014352 - Active, not recruiting
  stage III prostate cancer; stage IV prostate cancer; Thromboembolism; recurrent prostate cancer
  
• Long Term Open Follow-Up With H376/95 Vs. Warfarin
  ClinicalTrials.gov Identifier: NCT00206063 - Active, not recruiting
  Stroke Prevention in Patients With Atrial Fibrillation
  
• Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial
  ClinicalTrials.gov Identifier: NCT00041938 - Recruiting
  Heart Disease; Stroke; Ischemic Heart Disease; Myocardial Infarction; Atrial Fibrillation
  
• Duloxetine - Warfarin Pharmacodynamic Study
  ClinicalTrials.gov Identifier: NCT00533026 - Completed
  Anticoagulant Effect of Warfarin When Taken With Duloxetine.
  
• Penile Injection Anxiety
  ClinicalTrials.gov Identifier: NCT00582231 - Recruiting
  Penile Injection Therapy; Erectile Dysfunction; Radical Pelvic Surgery
  
• The Association of Warfarin Dosage and Plasma Enantiomer Concentration With the Gene Polymorphisms of CYP and VKOR
  ClinicalTrials.gov Identifier: NCT00247702 - Recruiting
  Deep Venous Thromboembolism
  
• Prolongation of the Interval Between Monitoring of Warfarin in Stable Patients
  ClinicalTrials.gov Identifier: NCT00356759 - Recruiting
  Atrial Fibrillation; Heart Valve Diseases; Venous Thrombosis
  
• Pilot Study of Aspirin Versus Warfarin for Cervicocephalic Arterial Dissection
  ClinicalTrials.gov Identifier: NCT00265408 - Active, not recruiting
  Ischemic Stroke; Cervicocephalic Arterial Dissection
  
• Comparison of Warfarin Dosing Using Decision Model vs. Pharmacogenetic Algorithm
  ClinicalTrials.gov Identifier: NCT00511173 - Recruiting
  Atrial Fibrillation; Pulmonary Embolism; Deep Vein Thrombosis
  
• PRospective Evaluation Comparing Initiation of Warfarin StrategiEs (PRECISE): Pharmacogenetic-Guided Versus Usual Care
  ClinicalTrials.gov Identifier: NCT00377143 - Recruiting
  Blood Coagulation Disorders
  
• Safety of KAI-9803 for Injection with Angioplasty following Heart Attack
  ClinicalTrials.gov Identifier: NCT00093197 - Active, not recruiting
  Myocardial Infarction
  
• Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00291330 - Recruiting
  Thromboembolism
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Warfarin Versus Aspirin Recurrent Stroke Study
  ClinicalTrials.gov Identifier: NCT00027066 - Completed
  Stroke
  
• Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00448396 - Recruiting
  Advanced Malignancies
  
• A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"
  ClinicalTrials.gov Identifier: NCT00334464 - Recruiting
  Atrial Fibrillation; Deep Vein Thrombosis; Pulmonary Embolism
  
• A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-Valvular Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00504556 - Recruiting
  Atrial Fibrillation; Thromboembolism
  
• Study of TLK199 HCl Liposomes for Injection in Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00035867 - Active, not recruiting
  Myelodysplastic Syndromes
  
• Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-Dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00580216 - Recruiting
  Atrial Fibrillation
  
• Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment
  ClinicalTrials.gov Identifier: NCT00548197 - Recruiting
  Intravitreal Bevacizumab Injection; Pars Plana Vitrectomy; Tractional Retinal Detachment; Diabetic Retinopathy
  
• Adverse Drug Reactions of Different Brands of Ceftazidime Injection
  ClinicalTrials.gov Identifier: NCT00173901 - Active, not recruiting
  Infection
  
• Topical Amethocaine Gel for Intramuscular Injection in Term Neonates
  ClinicalTrials.gov Identifier: NCT00267111 - Active, not recruiting
  Pain
  
• Validation of Self-Reported Needle Sharing Among Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00341081 - Active, not recruiting
  Viral Infection
  
• A Study Comparing Once Daily Oral Rivaroxaban With Adjusted-Dose Oral Warfarin for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00403767 - Recruiting
  Atrial Fibrillation; Stroke
  
• EPC by Intracoronary Injection in Patients With Chronic Stable Angina
  ClinicalTrials.gov Identifier: NCT00384514 - Active, not recruiting
  Coronary Artery Disease
  
• A Effectiveness and Safety Study of AQUAVAN® Injection (AQUAVAN; Fospropofol Disodium) for Sedation During Colonoscopy
  ClinicalTrials.gov Identifier: NCT00125424 - Active, not recruiting
  Colonoscopy; Colon Polyps; Endoscopic sedation; Endoscopic outcomes; Endoscopy
  
• The Necessity of an Injection-Meal-Interval in Patients With Type 2 Diabetes Mellitus and Therapy With Human Insulin
  ClinicalTrials.gov Identifier: NCT00529165 - Recruiting
  Diabetes Mellitus Type 2; Injection to Meal Time; Human Insulin
  
• Comparison Between Type A Botulinum Toxin Injection and Corticosteroid Injection in the Treatment of Tennis Elbow
  ClinicalTrials.gov Identifier: NCT00395616 - Recruiting
  Type A Botulinum Toxin; Tennis Elbow
  
• Safety and Effects of Implanted (Autologous) Skeletal Myoblasts (MyoCell) Using an Injection Catheter = SEISMIC Trial
  ClinicalTrials.gov Identifier: NCT00375817 - Active, not recruiting
  Myocardial Infarction; Heart Failure, Congestive
  
• Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
  ClinicalTrials.gov Identifier: NCT00192517 - Active, not recruiting
  Psoriasis
  
• A 2-Year Study of Patients With Schizophrenia Who Are Treated With Long-Acting Risperidone Injection.
  ClinicalTrials.gov Identifier: NCT00246194 - Active, not recruiting
  Schizophrenia
  
• IOP Reduction After Anecortave Acetate Injection in Glaucoma Patients
  ClinicalTrials.gov Identifier: NCT00533962 - Active, not recruiting
  Glaucoma; Intraocular Pressure
  
• Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00164372 - Active, not recruiting
  HIV Infections; Hepatitis C
  
• Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection
  ClinicalTrials.gov Identifier: NCT00491712 - Active, not recruiting
  Neovascular Glaucoma
  
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1
  ClinicalTrials.gov Identifier: NCT00218192 - Active, not recruiting
  HCV Negative Status; HCV Risk Behavior
  
• A Phase I/II Study of Chondrogen Delivered by Intra-Articular Injection Following Meniscectomy
  ClinicalTrials.gov Identifier: NCT00225095 - Active, not recruiting
  Recovery Following Partial Medial Meniscectomy
  
• Multicenter Study Of CPX-1 (Irinotecan HCl: Floxuridine) Liposome Injection In Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00361842 - Active, not recruiting
  Colorectal Neoplasms
  
• Doxorubicin HCI Liposome Injection Versus Weekly Docetaxel in Patients First Relapse Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00193037 - Active, not recruiting
  Breast Cancer
  
• Vitamin K Injections for the Treatment of Painful Menstruation
  ClinicalTrials.gov Identifier: NCT00104546 - Active, not recruiting
  Dysmenorrhea
  
• Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity
  ClinicalTrials.gov Identifier: NCT00580060 - Active, not recruiting
  Melanoma
  
• Randomized Study of Interventions to Enhance Adherence to Isoniazid Prevention Therapy for Tuberculosis in Injection Drug Users
  ClinicalTrials.gov Identifier: NCT00004740 - Active, not recruiting
  Tuberculosis
  
• Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads
  ClinicalTrials.gov Identifier: NCT00054951 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
  ClinicalTrials.gov Identifier: NCT00446082 - Active, not recruiting
  Carcinoid Tumor; Acromegaly
  
• Relationship Between Folic Acid and Warfarin Metabolism and Effect
  ClinicalTrials.gov Identifier: NCT00162409 - Recruiting
  Folic Acid Deficiency
  
• Patients Preference With Self-Injection: The PRISM Study
  ClinicalTrials.gov Identifier: NCT00253396 - Recruiting
  Bruises
  
• Safety and Efficacy of PolyHeme(R) in Hemorrhagic Shock Following Traumatic Injuries Beginning in the Pre-Hospital Setting
  ClinicalTrials.gov Identifier: NCT00076648 - Active, not recruiting
  Hemorrhagic Shock
  
• Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema
  ClinicalTrials.gov Identifier: NCT00344968 - Active, not recruiting
  Diabetic Macular Edema
  
• Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00394030 - Active, not recruiting
  Type 2 Diabetes Mellitus
  
• Study of Taxoprexin Injection vs. Dacarbazine in Patients with Metastatic Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00087776 - Active, not recruiting
  Malignant Melanoma
  
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control
  ClinicalTrials.gov Identifier: NCT00283049 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Study of TPI 287 in Patients with Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00113724 - Active, not recruiting
  Neoplasms
  
• A Study to Determine the Effectiveness and Safety of Risperidone in the Prevention of Bipolar Mood Episodes
  ClinicalTrials.gov Identifier: NCT00132678 - Active, not recruiting
  Bipolar Disorder
  
• Azithromycin/Bicillin for treatment of early syphilis
  ClinicalTrials.gov Identifier: NCT00031499 - Active, not recruiting
  Syphilis
  
• Treating High Risk Leukemia with CD40 Ligand & IL-2 Gene Modified Tumor Vaccine.
  ClinicalTrials.gov Identifier: NCT00058799 - Active, not recruiting
  Leukemia
  
• Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab
  ClinicalTrials.gov Identifier: NCT00417703 - Recruiting
  Choroidal Neovascularization
  
• Botulinum Toxin Injection for the Management of BPH
  ClinicalTrials.gov Identifier: NCT00451191 - Recruiting
  Benign Prostatic Hyperplasia
  
• Dysport® Injection in the Treatment of Chronic Lateral Epicondylitis
  ClinicalTrials.gov Identifier: NCT00497913 - Recruiting
  Tennis Elbow
  
• A Phase 2 open-label clinical study using intravenous Paxceed™ to treat patients with rheumatoid arthritis
  ClinicalTrials.gov Identifier: NCT00055133 - Active, not recruiting
  Rheumatoid Arthritis
  
• ATX-101 (Sodium Deoxycholate for Injection) for the Treatment of Superficial Lipomas
  ClinicalTrials.gov Identifier: NCT00422188 - Recruiting
  Lipoma
  
• The ORIGIN Trial (Outcome Reduction with Initial Glargine Intervention)
  ClinicalTrials.gov Identifier: NCT00069784 - Active, not recruiting
  Diabetes Mellitus, Non-Insulin-Dependent
  
• Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma
  ClinicalTrials.gov Identifier: NCT00307606 - Recruiting
  Breast Neoplasms; Mastectomy
  
• To Find the Best Dose of pVGI.1(VEGF2) to Benefit Angina Patients when given with an Experimental Injection Catheter
  ClinicalTrials.gov Identifier: NCT00090714 - Active, not recruiting
  Angina Pectoris
  
• Safety and Effectiveness of SeeMore (EVP 1001-1 Injection) for MRI in Heart Patients
  ClinicalTrials.gov Identifier: NCT00340925 - Recruiting
  Myocardial Infarction
  
• Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation
  ClinicalTrials.gov Identifier: NCT00575744 - Recruiting
  Breast Cancer
  
• An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00229658 - Active, not recruiting
  Type 1 Diabetes Mellitus; Type 2 Diabetes Mellitus
  
• A Study to Evaluate Nutropin AQ for the Treatment of Growth Restriction in Children with Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00079742 - Active, not recruiting
  Cystic Fibrosis
  
• Injection Methods in Finding the Sentinel Lymph Node During Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Invasive Breast Cancer
  ClinicalTrials.gov Identifier: NCT00438477 - Active, not recruiting
  Breast Cancer
  
• Comparison Study of Operation and Percutaneous Ethanol Injection Therapy for Small, Solitary HCC
  ClinicalTrials.gov Identifier: NCT00357422 - Recruiting
  Hepatocellular Carcinoma
  
• Comparison Study of Transarterial Chemoembolization and Percutaneous Ethanol Injection for Multiple, Small HCCs
  ClinicalTrials.gov Identifier: NCT00357474 - Recruiting
  Hepatocellular Carcinoma
  
• Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00364143 - Recruiting
  Cancer
  
• The Impact of an Epidural Ropivacaine-Neostigmine Injection for Perineal Analgesia at the End of Labor.
  ClinicalTrials.gov Identifier: NCT00407290 - Recruiting
  Pregnancy; Vaginal Delivery
  
• Sub-Tenon’s Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery
  ClinicalTrials.gov Identifier: NCT00431028 - Recruiting
  Inflammation; Bacterial Infections
  
• This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo.
  ClinicalTrials.gov Identifier: NCT00479596 - Recruiting
  Overactive Bladder
  
• Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00064610 - Active, not recruiting
  Prostatic Neoplasms
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis
  ClinicalTrials.gov Identifier: NCT00314366 - Recruiting
  Coronary Artery Disease
  
• Corticosteroid Injection for Common Upper Extremity Problems
  ClinicalTrials.gov Identifier: NCT00438672 - Recruiting
  Lateral Elbow Pain; deQuervain’s Tendonitis; CMC Arthritis
  
• Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00461955 - Recruiting
  Multiple Myeloma
  
• A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD
  ClinicalTrials.gov Identifier: NCT00536016 - Recruiting
  Macular Degeneration
  
• Hyaluronan Versus NaCl 20 Ml Versus Placebo in Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00144820 - Active, not recruiting
  Osteoarthritis, Knee
  
• Phase 2b Study of VELCADE Alone and VELCADE plus Irinotecan in Patients with Relapsed or Refractory Colorectal Carcinoma
  ClinicalTrials.gov Identifier: NCT00051987 - Active, not recruiting
  Colorectal Carcinoma
  
• Safety Study of MBP-426 (Liposomal Oxaliplatin Suspension for Injection) to Treat Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00355888 - Recruiting
  Cancer
  
• Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
  ClinicalTrials.gov Identifier: NCT00553488 - Recruiting
  Diabetes Mellitus, Type 1
  
• Factors Predicting Efficacy of Allergen Injection Immunotherapy for Grass Pollen Hayfever: a Pilot Study.
  ClinicalTrials.gov Identifier: NCT00135629 - Active, not recruiting
  Seasonal Allergic Rhinoconjunctivitis
  
• Valganciclovir in Patients with CMV Retinitis and AIDS Who Cannot Take Drugs by Injection
  ClinicalTrials.gov Identifier: NCT00017784 - Active, not recruiting
  Cytomegalovirus Retinitis; HIV Infections
  
• Vincristine, DOXIL® (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00344422 - Active, not recruiting
  M-Protein; Multiple Myeloma; Myeloma; Myeloma Proteins
  
• Depo-Provera: Evaluation of BMDensity and Total Body Ca Adolescent DP150CI Users and Non-Hormonal Contraception
  ClinicalTrials.gov Identifier: NCT00139685 - Active, not recruiting
  Contraception; Bone Density
  
• Evaluation of the Effects of L-Carnitine Injection in Patients Undergoing Hemodialysis
  ClinicalTrials.gov Identifier: NCT00173706 - Recruiting
  Cardiac Complications; Signs and Symptoms; Muscle Weakness; Anemia; Hypotension
  
• Thal/Dex (Thalidomide and Dexamethasone) vs. Dd-T (Doxil, Dexamethasone and Thalidomide) in Multiple Myeloma Patients
  ClinicalTrials.gov Identifier: NCT00097981 - Active, not recruiting
  Multiple Myeloma